D
NA methylation plays a central role in human development and cellular identity [1] [2] [3] [4] [5] [6] . Dynamic CpG methylation throughout cell differentiation correlates with cell type-specific gene regulation and expression levels, with loss of methylation reflecting enhancer or gene activation [7] [8] [9] [10] . The majority of CpGs in differentiated cells are uniformly methylated or unmethylated between homologous chromosomes and within cell populations composed of a single cell type. The bimodality of DNA methylation implies a binary on-off control over gene expression, yet a significant number of loci throughout the genome do not fit within this model.
Regions of intermediate methylation (IM) may exhibit allelic methylation, intercellular variability or clusters of interspersed methylated and unmethylated CpGs within each cell. A small number of genes are marked by allele-specific methylation (ASM), including imprinting control regions (ICRs), which are essential for mammalian development [11] [12] [13] [14] [15] [16] [17] . Other IM states, including non-allelic IM, may also be functional and potentially dynamically regulated during development 7, 18, 19 . The level of methylation reported in IM regions in prior studies is variable, but typically much less than the 50% that typifies ICRs 7, 18, 19 . The prevalence of IM states and their function within genetically and phenotypically homogenous cell populations has been enigmatic.
Here, we use genome-wide DNA methylation profiling to identify and compare IM regions across human tissues and primary cell types, and among individuals. We define boundaries of IM loci by combining two independent and complementary enrichment-based methods that, respectively, identify methylated and unmethylated regions of DNA. We then validate and quantify methylation levels at basepair resolution within IM regions using whole-genome bisulfite sequencing (WGBS) and methylation array data. We analyse multiple cell types from the same individual to distinguish cell type epigenetic differences from genetic effects on the epigenome. We then examine the relationship between IM states, associated histone marks of gene regulation, mRNA levels and exon usage from the same samples used to discover the IM regions. We further use these data, along with in vivo enhancer assay data and evolutionary conservation, to discover potential functions of IM states.
Results

IM is closely associated with genes.
To identify regions of IM, we combined two complementary whole-methylome profiling methods: MeDIP-Seq, which targets methylated DNA using an anti-methylcytosine antibody; and MRE-Seq, which identifies unmethylated DNA by methylation-sensitive restriction enzyme digestions. This experimental approach was chosen because nearly all mapped reads are informative, contrasting to the inefficiency of WGBS in which 70-80% of sequence reads are uninformative because they lack CpG sites 10 . Furthermore, 5-methylcytosine and 5-hydroxymethylcytosine are conflated in WGBS, whereas MeDIP/MRE-Seq detect 5-methylcytosine exclusively. MeDIP/MRE-Seq may also provide greater accuracy in a minority of loci 20 . Most importantly, identification of IM with MeDIP/MRE-Seq does not assume a binary state, as IM are identified by strong and overlapping signals from each assay. We applied MeDIP/MRE-Seq 8, [20] [21] [22] [23] to 23 human primary cell and tissue samples isolated without culturing from three tissue types and seven donors 24 , and two biological replicates of the H1 embryonic stem cell line (H1ES) 23 (see Methods). The diverse set of samples we profiled allowed controlled comparisons of different cell types from the same individual, and identical cell types from different age-matched donors.
A small fraction of CpGs in each sample showed signal enrichment in both MeDIP-Seq and MRE-Seq, indicating simultaneous presence of methylated and unmethylated DNA ( Fig. 1a and Supplementary Fig. 1a ). We developed a maximum scoring segment algorithm to define boundaries of IM regions representing clusters of neighbouring CpGs with co-occurring enrichment in MeDIP/MRE-Seq (Methods; Supplementary  Fig. 1b) . Altogether, 18,452 unique autosomal IM regions were detected in one or more samples, containing 2% of the 26.9 million CpGs interrogated. Within IM regions, we estimated the methylation levels at single CpGs using WGBS from H1ES cells and Illumina 450K Infinium Methylation Array data from eight of our samples. WGBS and methylation arrays confirmed the primarily bimodal genome-wide distribution of fully methylated and unmethylated CpGs. Individual CpGs within regions classified as IM, however, had a mean methylation of 57% (WGBS) and 58% (arrays; Fig. 1a ). In the majority of regions, the IM state was restricted to one or a subset of tissue or cell types, although 1,754, or 9%, were present across all tissues studied (constitutive IM; Fig. 1b-e) . Hierarchical clustering based on the presence or absence of the IM status or based on MeDIP/ MRE-Seq read density at the union set of IM regions strongly separated cell types isolated from different tissues ( Fig. 1c and Supplementary Fig. 2 ).
We detected an average of 7,531 autosomal IM regions per sample, with a mean length of 271 bp. We selected the union of IM regions across all samples (n ¼ 18,452) as a reference set for further analysis. Over half of IM regions were intragenic or were within 3 kb of 6,798 autosomal genes (36% of genes; odds ratio ¼ 1.27; P-valueo0.001, w 2 ). IM regions were enriched at promoters, exons and DNase I hypersensitivity sites (DHSs), and confirmed 17 of 19 known imprinted loci (Fig. 2a,b and Supplementary Figs 2a and 3) . Thus, IM regions were associated with a significant number of genes and potential regulatory regions.
Approximately 50% of IM regions overlapped loci identified as differentially methylated across cell and tissue types 10 , consistent with our observation that IM is often tissue-specific. However, most studies comparing methylation between cell types examine only the binary direction of the methylation change (hypo-or hypermethylated) rather than the methylation level maintained within each cell type. Thus, differential methylation as previously defined does not identify specific regions as IM. The majority (69%) of IM regions reported here have not been previously identified as having allele-specific or stable IM states within a population of cells of a single type 7, 17, 18, 25, 26 ( Supplementary  Fig. 5a,b) .
Level of histone modification and DHS at IM. To determine whether IM regions could have regulatory function, we next performed chromatin immunoprecipitation sequencing (ChIP-Seq) for selected histone modifications that demarcate active regulatory elements, using the same cell samples in which IM regions were mapped. Within a given sample, we explored the relationship between DNA methylation level and histone modification levels by comparing histone ChIP-Seq signal at IM regions to signal at regions that were methylated and unmethylated in the same sample used for ChIP-Seq, but which had IM status in other samples. Consistent with prior studies, the normalized read densities for the active marks of H3K4me1 and H3K4me3 were anti-correlated with DNA methylation. Interestingly, signal strength for these modifications at regions with IM status consistently fell between signals at methylated and unmethylated sites, providing a novel association of IM with intermediately active chromatin states (Fig. 2c) . Furthermore, DHS in H1ES cells or in fetal brain had a similar intermediate state at their IM regions, respectively (Fig. 2d) .
Enhancer regions predicted by chromHMM 27 using the celltype-matched ChIP-Seq data were more enriched for IM CpGs than the genomic background of methylated (MeDIP-Seq only) or unmethylated (MRE-Seq only) CpGs (Supplementary Methods and Supplementary Fig. 3 ). We therefore asked if IM regions coincide with functional regulatory elements defined by in vivo transgenic reporter assays. Of 70 candidate enhancers defined by the VISTA project that we also identified as IM regions, 50 drove transgene expression in mouse embryos 28 -a higher validation rate than VISTA candidates tested from non-IM regions. Methylation levels of enhancers in the reporter construct are unknown, however, this result demonstrates that many IM regions coincide with functional enhancers (Supplementary Data 1). A small portion of IM regions (9.5%) in fetal brain also shows increased 5 hmC in fetal brain relative to adult brain 29 ( Supplementary Fig. 5c ).
Level of gene expression and exon inclusion near IM. We hypothesized that the DNA methylation level in IM regions might correspond to a difference in the level of transcription of the associated gene. To examine this relationship, we initially focused on IM regions occurring within 10 kb of transcription start sites in breast myoepithelial cells. For comparison, we applied the same selection criteria to methylated and fully unmethylated regions in myoepithelial cells that had IM status in other cell types. Methylated and unmethylated status at these regions distinguished proximal genes with significantly different mean expression values, following the established inverse correlation between DNA methylation at enhancers and gene expression. Remarkably, despite an average DNA methylation level of 63% in myoepithelial cells based on methylation array, regions with IM status corresponded to a set of genes with mean expression distinct from both the methylated and unmethylated sets (Po0.005, Wilcoxon), suggesting that enhancers with IM are associated with intermediate levels of gene expression (Fig. 2e) .
IM regions were dramatically enriched at coding exons (Supplementary Methods and Supplementary Fig. 3 ). Exons associated with IM were defined as exons with at least one IM region in the exon or within 1 kb of the exon boundaries. To investigate the potential function of exonic IM, we calculated expression of each exon relative to the expression of its gene as a measure of exon inclusion in the transcript, and compared this relative expression of IM exons to that of methylated or unmethylated exon-associated regions. Interestingly, the relationship between methylation and relative exon expression was the opposite of that observed between expression and methylation at candidate enhancers. Methylated regions were associated with the highest exon inclusion, whereas unmethylated regions showed the lowest exon inclusion, IM states being associated with intermediate inclusion (Po0.001, Wilcoxon; Fig. 2e ). These results were consistent with previous reports using binary classification of DNA methylation states 30 and extended the relationship specifically to the IM state. Therefore, the level of DNA methylation could potentially affect either gene expression or exon inclusion rates in a more quantitative manner than previously appreciated, although functional assays will be needed.
IM is predominantly allele independent. IM CpGs could reflect ASM or allele-independent methylation (AIM). Interestingly, most previously identified ASM has not been connected to allelic gene expression 14, 17 . To distinguish ASM from AIM, we identified heterozygous single-nucleotide polymorphisms (SNPs) in the autosomal IM regions and determined the allelic preference of sequencing reads from MeDIP/MRE-Seq, where ASM segregated heterozygous SNPs between the two assays (Methods). We identified a total of 2,072 ASM SNPs (721 unique across samples) and 5,895 AIM SNPs (3,262 unique; Fig. 3a,b) . We then categorized each IM region as ASM or AIM if it contained two or more ASM or AIM SNPs (Methods). We identified 109 ASM regions and 927 AIM regions (Fig. 3b ). ARTICLE From these data, we infer that the methylation pattern underlying a majority of IM regions is allele independent rather than allele specific. ASM should have approximately 50% methylation at individual CpGs, whereas IM due to intercellular heterogeneity could theoretically fall at any IM value. On the methylation arrays, methylation scores of CpGs within ICRs and our predicted ASM had a relatively narrow distribution centred near 50%. Methylation scores at AIM regions peaked near 50% but had a broader distribution, consistent with the presence of more intercellular variation at individual CpGs, and potentially across neighbouring CpGs (Fig. 3c) .
We selected 36 high confidence IM regions (based on MeDIP/ MRE-Seq signal strength) for validation by bisulfite, PCR, cloning and sequencing. A total of 35 loci validated as IM (97%), including 12 of 14 ASM (86%; 2 predicted as ASM were found to be AIM; Fig. 3a ) and 12 of 12 AIM (100%) regions. Interestingly, the AIM regions exhibited an interspersed mixture of methylated and unmethylated CpGs on each clone (Supplementary Fig. 6 and Supplementary Data 2). Thus, the intermediate signals in H3K4me1, H3K4me3 and DHSs at IM regions cannot be attributed to fully unmethylated alleles in an ASM configuration. Potential configurations include intercellular heterogeneity, differences in neighbouring nucleosomes and differences between individual subunits within each nucleosome.
To examine the relationship between ASM and histone modifications, we measured allelic preference for histone signals at ASM loci and compared this to the allelic preference of MeDIP/MRE-Seq signals at the same locations (Fig. 3d) . We focused on heterozygous SNPs from the two fetal brain samples with genotype validated by whole-genome sequencing. At loci classified as ASM, the active chromatin marks H3K4me3 and H3K4me1 showed a clear preference for the unmethylated allele, whereas the repressive mark H3K9me3 had a bias towards the methylated allele. Interestingly, the repressive mark H3K27me3 preferentially occurred on the unmethylated allele. In contrast, histone modifications at AIM and fully unmethylated regions did not exhibit a strong allelic preference ( Supplementary Fig. 4 ). IM state is evolutionarily conserved. As a complementary comparative epigenomics approach to investigate whether IM regions may have function, we identified IM states using MeDIP/ MRE-Seq data from murine embryonic stem (ES) cells and fetal neurons, taking the union of regions in both cell types as the reference IM set for mouse. A total of 13,623 IM regions were detected in the two mouse samples. We then determined how frequently IM states in the mouse genome were conserved as IM in human. After mapping mouse IM regions to their syntenic loci in the human genome, 17.4% directly overlapped human IM regions, representing a 14-fold enrichment over random expectation (Po0.001, w 2 ), and suggesting significant cross-species conservation of the IM state (Fig. 4a,b) . When restricting the human IM set to only the two human tissues (ES and fetal brain) that were also profiled from mouse, the enrichment increased to nearly 19-fold, suggesting that tissue specificity of IM is also conserved. Averaged phastCons scores over IM regions indicated DNA sequence conservation that reached its maximum at the centre of the region, even when coding exons were excluded (Fig. 4c) . Although an individual CpG is either methylated or unmethylated, our results raise the possibility that local clusters of CpGs provide quantitative instructions for gene regulation or exon usage that exists stably between fully 'on' and 'off' states within single-cell types. Intriguingly, we approximate that 18% or fewer IM regions are allele-specifically methylated, whereas the majority is allele independent, suggesting that the predominant mode of IM establishment relies on epigenetic heterogeneity at a precise loci within cell populations. Methods to create and abolish IM states in a locus-specific manner will be required to further examine these possibilities 31 .
Widespread intercellular and allelic stochasticity of gene expression has been observed in single-cell mRNA sequencing data [32] [33] [34] ; however, it is not clear why some genes exhibit stochastic expression while others are uniformly expressed, or if a biological mechanism might be needed to establish or control intercellular differences. A quantitative model of epigenetic gene regulation that includes stable, tissue-specific intermediate states may help explain variations in gene activity between cells of the same type. Although this remains to be proven, it would have far-reaching implications for the multitude of diseases linked to disruption of DNA methylation, including the epigenetic heterogeneity in cancer cells 35, 36 .
Methods
Sample preparation. All assays were performed as part of the repository of the NIH Roadmap Epigenomics Mapping Centers for the reference Human Epigenome Atlas 37 .
Blood. Buffy coats were obtained from the Stanford Blood Center (Palo Alto, California, USA). Blood was drawn and processed on the same day. Peripheral blood mononuclear cells (PBMCs) were isolated by Histopaque-1077 (Sigma-Aldrich) density-gradient centrifugation according to the manufacturer's protocol. Further purification of memory CD4 þ , naive CD4 þ and naive CD8 þ T lymphocytes was performed using a RoboSep instrument and the isolation kit for each subpopulation (EasySep Human Memory CD4 þ T Cell Enrichment kit, EasySep Human Naive CD4 þ T Cell Enrichment kit and Custom Human Naive CD8 þ T Cell Enrichment kit; STEMCELL Technologies). Total PBMCs were karyotyped (Molecular Diagnostic Services) and analysed to determine the percentage of cells in each cell cycle stage (G0/G1, S and G2/M). PBMC and T-cell subpopulations were stained with antibodies (anti-CD3 TRI-COLOR (Invitrogen), anti-CD4 PE (BD Biosciences), anti-CD8 FITC (BD Biosciences), anti-CD4 TRI-COLOR (Invitrogen), anti-CD45RO PE (Invitrogen), anti-CD45RA FITC (BD Biosciences) and anti-CD8 TRI-COLOR (Invitrogen)) and analysed by fluorescence-activated cell sorting for purity. Cells were aliquoted for isolation of either DNA or RNA and were washed in PBS. Cell pellets for RNA purification were resuspended in 1 ml of TRIzol reagent (Invitrogen) and frozen at À 80°C. Cell pellets for DNA purification were flash frozen in liquid nitrogen and stored at À 80°C. Antibodies used included TRI-COLOR-conjugated antibody to CD3 (Invitrogen, MHCD0306), Phycoerythrin- conjugated antibody to CD4 (BD Biosciences, 340419), fluorescein isothiocyanate (FITC)-conjugated antibody to CD8 (BD Biosciences, 561947), TRI-COLOR-conjugated antibody to CD4 (Invitrogen, MHCD0406), PE-conjugated antibody to CD45RO (Invitrogen, MHCD45RO04), FITC-conjugated antibody to CD45RA (BD Biosciences, MHCD45RA01) and TRI-COLOR-conjugated antibody to CD8 (Invitrogen, MHCD0806). All antibodies were used according to the manufacturer's instructions.
Breast. Breast tissues were obtained from disease-free premenopausal women undergoing reduction mammoplasty in accordance with institutional review board protocol 10-01563 (previously CHR 8759-34462-01). All tissues were obtained as de-identified samples and were linked only with a minimal data set (age, ancestry and, in some cases, parity/gravidity). All study subjects provided written informed consent. Tissue was dissociated mechanically and enzymatically 38 . Briefly, tissue was minced and dissociated in RPMI 1640 with L-glutamine and 25 mm HEPES (Fisher) supplemented with 10% fetal bovine serum (FBS; JR Scientific), 100 U ml À 1 penicillin, 100 mg ml À 1 streptomycin sulfate, 0.25 mg ml À 1 Fungizone, 50 mg ml À 1 gentamicin sulfate (Lonza), 200 U ml À 1 collagenase 2 (Worthington) and 100 U ml À 1 hyaluronidase (Sigma-Aldrich) at 37°C for 16 h. The cell suspension was centrifuged at 395 g for 10 min, and the pellet was washed with RPMI 1640 supplemented with 10% FBS. Clusters enriched in epithelial cells (referred to as organoids) were recovered after serial filtration through 150-mm nylon mesh (Fisher) and 40-mm nylon mesh (Fisher). The final filtrate contained primarily mammary stromal cells (fibroblasts, immune cells and endothelial cells) and some single epithelial cells. After centrifugation at 290 g for 5 min, the epithelial organoids and filtrate were frozen for long-term storage. The day of cell sorting, epithelial organoids were thawed and further digested with 0.5 g l À 1 trypsin, 0.5 mM EDTA, pH 8.0, and dispase DNase I (STEMCELL Technologies).
Generation of single-cell suspensions was monitored visually. Single-cell suspensions were filtered through a 40-mm cell strainer (Fisher), spun down and allowed to regenerate in mammary epithelial cell growth medium (Lonza) supplemented with 2% FCS for 60-90 min at 37°C. This regeneration step enables quenching of trypsin and re-expression of the cell surface markers before staining, which was need because their extracellular domains had been cleaved by trypsin. The single-cell suspension obtained was stained for cell sorting with three human-specific primary antibodies, including antibody to CD10 labelled with PE-Cy5 (BD Biosciences, 555376) to isolate myoepithelial cells, antibody to CD227/MUC1 labelled with FITC (BD Biosciences, 559774) to isolate luminal epithelial cells and antibody to CD73 labelled with PE (BD Biosciences, 550257) to isolate a stem cell-enriched cell population, as well as with biotinylated antibodies for lineage markers, including antibodies to CD2 (555325), CD3 (555338), CD16 (555405), CD64 (555526) (all from BD Biosciences), CD31 (Invitrogen, MHCD3115), CD45 (BioLegend, 304003) and CD140b (BioLegend, 323604) to specifically remove haematopoietic (CD16-and CD64-positive), endothelial (CD31-positive), leukocytic (CD2-, CD3-or CD45-positive) and mesenchymal (CD140b-positive) lineage cells by negative selection. Sequential incubation with primary antibodies was performed for 20 min at room temperature in PBS with 1% BSA, and cells were washed in PBS with 1% BSA. Biotinylated primary antibodies were detected with a secondary antibody to human immunoglobulin labelled with streptavidin-Pacific Blue conjugate (Invitrogen, S11222). After incubation, cells were washed once in PBS with 1% BSA, and cell sorting was performed using a FACSAria II cell sorter (BD Biosciences). Fetal brain. Post-mortem human fetal neural tissues were obtained from a case of twin non-syndrome fetuses whose death was attributed to environmental/placental aetiology. Tissues were obtained with appropriate consent according to the Partner's Healthcare/Brigham and Women's Hospital Institutional Review Board guidelines (protocol 2010P001144). All samples and tissues were de-identified and linked only with a minimal data set (age, sex and brain location). Fetal brain tissue and fetal neural progenitor cells were derived from manually dissected regions of the brain (telencephalon), specifically the neocortex (pallium; GSM669614 and GSM669615). Tissues were minced and dissociated by mechanical agitation (gentle-MACS device) during enzymatic treatment with papain according to the manufacturer's protocol (Miltenyi Biotec, Neural Tissue Dissociation kit). Cell suspensions were then washed twice in Dulbecco's modified Eagle medium (DMEM) and plated at low density in human NeuroCult NS-A medium (STEMCELL Technologies) supplemented with heparin, epidermal growth factor (20 ng ml À 1 ) and fibroblast growth factor (10 ng ml À 1 ) in ultra-low-attachment cell culture flasks (Corning).
H1 embryonic stem cells. H1 cells were grown in mTeSR1 medium on Matrigel (BD Biosciences) for ten passages on 10 cm 2 plates and harvested at passage 27. Cells were harvested by scraping before snap freezing for DNA isolation. Cells were also harvested from passages 30 and 32 and divided for isolation of DNA, RNA and chromatin 23 .
Mouse embryonic stem cells and fetal neurons. Mouse embryonic stem cells (E14) were plated onto gelatin-coated dishes in DMEM (GIBCO), supplemented with 15% heat-inactivated FBS (GIBCO), 0.055 mM mercaptoethanol (GIBCO), 2 mM L-glutamine, 0.1 mM MEM non-essential amino acid, 5,000 U ml À 1 penicillin/streptomycin and 1,000 U ml À 1 of LIF (Millipore ESG1107) in an incubator set at 37°C and 5% CO 2 (MeDIP-Seq: GSM881346; MRE-Seq: GSM881347). Studies were conducted with the approval of the University of California San Diego Internal Review Board and Animal Studies Committee.
Cortical neurons from E15 CD-1 mice (Charles River Laboratories) were processed as described for mouse dorsal root ganglion primary cultures (protocol number 20140044) 39 . The animal studies committee at the Washington University School of Medicine approved the experiments. Gestational day 12.5-13 embryos were removed and cells were dissected out and dissociated using 0.5 ml trypsin/ EDTA (0.05%/0.02%; Tissue Culture Support Center, Washington University, St Louis, MO, USA) for no longer than 15 min at 37°C with two or three times of gentle shaking by hand. The reaction was stopped by addition of 0.5 ml of DMEM/ 10% FBS. All subsequent procedures were performed in a laminar flow hood under sterile condition. Cells were gently triturated by pipetting them up and down with a sterile P1000 pipetman less than ten times. No cell clumps should be visible after this trituration. Cell suspensions were centrifuged at 2,000 r.p.m. for 5 min at room temperature. Supernatants were completely removed. Cell pellets were washed twice with 1 ml of DMEM/10% FBS. Cells were resuspended in either DMEM/10% FBS or growth medium, plated and cultured in neurobasal medium (Invitrogen #21103-049) with B27 serum-free supplement (Invitrogen #17504-044), glutamine (5 mM) and penicillin/streptomycin. Cells were typically seeded at a density of 'one forebrain per 24-well plate'. Neurons were stimulated with KCl (55 mM) at 5 days in vitro for 4 h (ref. 40) .
Chromatin immunoprecipitation sequencing. Standard operating procedures for ChIP-seq library construction are available at http://www.roadmapepigenomics. org/protocols/type/experimental/. ChIP-seq library construction involves the following protocols in order: (i) cross-linking of frozen cell pellet, (ii) DNA sonication using Sonic Dismembrator 550 and (iii) SLX-PET protocol for Illumina sample preparation. Antibodies used in this study were subjected to rigorous quality assessment to meet Reference Epigenome Mapping Quality Standards (http:// www.roadmapepigenomics.org/protocols) including western blotting of whole-cell extracts, 384 peptide dot blot (Active Motif MODified Histone Peptide Array) and ChIP-seq using control cell pellets (HL60). Antibody vendor, catalogue number and lot are provided along with ChIP-seq library construction details as part of the metadata associated with all ChIP-seq data sets and are available through GEO and the NCBI epigenomics portals (for example, http://www-ncbi-nlm-nih-gov. beckerproxy.wustl.edu/geo/query/acc.cgi?acc ¼ GSM613811). Final library distributions were calculated using an Agilent Bioanalyzer and quantified by fluorometric quantification (Qubit, Life Technologies). Libraries were sequenced using single-end 76 nt sequencing chemistry on an Illumina GAiix or HiSeq2000 following the manufacturer's protocols (Illumina) as either single or multiplexed libraries using custom index adapters added during library construction.
Sequencing reads were aligned to NCBI GRCh37-lite reference using BurrowsWheeler Alignment tool (BWA) 0.6.2-r126 with default parameters. MethylQA (an unpublished C programme; available at http://methylqa.sourceforge.net/) was used to directionally extend aligned reads to the average insert size of DNA fragments (150 bp) and to generate a bigWig file for downstream visualization. Reads with BWA mapping quality scores o o10 were discarded and reads that aligned to the same genomic coordinate were counted only once.
Methylation-sensitive restriction enzyme-seq. Methylation-sensitive restriction enzyme (MRE)-seq was performed as in Maunakea et al. 22 , with modifications as detailed below. Five parallel restriction enzyme digestions (HpaII, Bsh1236I, SsiI(AciI) and Hin6I (Fermentas), and HpyCH4IV (NEB)) were performed, each using 1 mg of DNA per digest for each of the skin cell type samples. Five units of enzyme were initially incubated with DNA for 3 h and then an additional five units of enzyme was added to the digestion for a total of 6 h of digestion time. DNA was purified by phenol/chloroform/isoamyl alcohol extraction, followed by chloroform extraction using phase lock gels. Digested DNA from the different reactions was combined and precipitated with one-tenith volume of 3 M sodium acetate (pH 5.2) and 2.5 volumes of ethanol. The purified DNA was size selected and purified (50-300 bp) by gel electrophoresis and Qiagen MinElute extraction. Library construction was performed as per the Illumina Genomic DNA Sample Prep Kit protocol with the following modifications. During the end-repair reaction, T4 DNA polymerase and T4 PNK were excluded and 1 ml of 1:5 diluted Klenow DNA polymerase was used. For the adapter ligation reaction, 1 ml of 1:10 diluted PE adapter oligo mix was used. Ten microlitres from the 30 ml of purified adapter ligated DNA was used for the PCR enrichment reaction with PCR PE Primers 1.0 and 2.0. PCR products were size selected and purified (170-420 bp) by gel electrophoresis and Qiagen Qiaquick extraction. DNA libraries were checked for quality by Nanodrop (Thermo Scientific) and Agilent DNA Bioanalyzer (Agilent).
Reads were aligned to hg19 using the BWA and pre-processed using methylQA (an unpublished C programme; available at http://methylqa.sourceforge.net/). MRE reads were normalized to account for differing enzyme efficiencies and methylation values were determined by counting reads with CpGs at fragment ends 22 . To enable comparison between MRE-seq data from blood, brain and breast samples that used three restriction enzymes and skin cell types that used five restriction enzymes, skin cell-type MRE reads that resulted from the use of additional restriction enzymes (Bsh1236I and HpyCH4IV) were removed. Detailed library NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7363 ARTICLE construction protocols for MRE-seq, methylated DNA immunoprecipitation-seq (MeDIP-seq), ChIP-seq, RNA-seq and miRNA-seq are publicly available at the NIH Roadmap Epigenomics project website http://www.roadmapepigenomics.org/ protocols/type/experimental/.
Methylated DNA immunoprecipitation-seq. MeDIP-seq was performed as in Maunakea et al. 22 Five micrograms of genomic DNA were sonicated to a fragment size of B100-400 bp using a Bioruptor sonicator (Diagenode). End-repair, addition of 3 0 -A bases and PE adapter ligation with 2 mg of sonicated DNA was performed as per the Illumina Genomic DNA Sample Prep Kit protocol. Adapterligated DNA fragments were size selected to 166-366 bp and purified by gel electrophoresis. DNA was heat denatured and then immunoprecipitated with 5-methylcytidine antibody (Eurogentec; 1 mg of antibody per 1 mg of DNA) in 500 ml of immunoprecipitation buffer (10 mM sodium phosphate, pH 7.0, 140 mM sodium chloride and 0.05% Triton X-100) overnight at 4°C. Antibody/DNA complexes were isolated by addition of 1 ml of rabbit anti-mouse IgG secondary antibody (2.4 mg ml À 1 , Jackson Immunoresearch) and 100 ml protein A/G agarose beads (Pierce Biotechnology) for 2 h at 4°C. Beads were washed six times with immunoprecipitation buffer and then DNA was eluted in TE buffer with 0.25% SDS and 0.25 mg ml À 1 of proteinase K for 2 h at 50°C. DNA was then purified with the Qiagen Qiaquick kit and eluted in 30 ml EB buffer. Ten microlitres of DNA were used for a PCR-enrichment reaction with PCR PE Primers 1.0 and 2.0. PCR products were size selected (220-420 bp) and purified by gel electrophoresis. Methylated DNA enrichment was confirmed by PCR on known methylated (SNRPN and MAGEA1 promoters) and unmethylated (a CpG-less sequence on chromosome 15 and glyceraldehyde 3-phosphate dehydrogenase promoter) sequences. DNA libraries were checked for quality by Nanodrop (Thermo Scientific) and Agilent DNA Bioanalyzer (Agilent). Reads were aligned to hg19 using BWA and pre-processed using methlyQA. Briefly, polyA þ RNA was purified using the MACS mRNA isolation kit (Miltenyi Biotec), from 2 to 10 mg of total RNA with a RNA integrity number Z7 (Agilent Bioanalyzer) as per the manufacturer's instructions. The process included oncolumn DNaseI treatment (Invitrogen). Double-stranded cDNA was synthesized from the purified polyA þ RNA using the Superscript II Double-Stranded cDNA Synthesis kit (Invitrogen) and 200 ng random hexamers (Invitrogen). After first strand synthesis, dNTPs were removed using two volumes of AMPure XP beads (Beckman Genomics). GeneAmp (Invitrogen) 12.5 mM dNTPs blend (2.5 mM dCTP, 2.5 mM dGTP, 2.5 mM dATP, 5.0 mM dUTP) was used in the second strand synthesis mixture in the presence of 2 mg of ActinomycinD. Double-stranded cDNA was purified using two volumes of Ampure XP beads, fragmented using Covaris E series shearing (20% duty cycle, Intensity 5, 55 s), and used for pairedend sequencing library preparation (Illumina). Before library amplification uridine digestion was performed at 37°C for 30 min following with 10 min at 95°C in Qiagen Elution buffer (10 mM Tris-Cl, pH 8.5) with 5 U of Uracil-N-Glycosylase (AmpErase). The resulting single-stranded sequencing library was amplified by PCR (10-13 cycles) to add Illumina P5 and P7 sequences for cluster generation. PCR products were purified on Qiaquick MinElute columns (Qiagen), and assessed and quantified using an Agilent DNA 1000 series II assay and Qubit fluorometer (Invitrogen), respectively. Libraries were sequenced using paired-end 76 nt sequencing chemistry on a cBot and Illumina GA iix or HiSeq2000 following the manufacturer's protocols (Illumina).
Whole-genome sequencing. Two micrograms of extracted DNA were sheared for 55 s using a Covaris E210 focused ultra-sonicator (Covaris Inc.) at 20% Duty cycle, 5% Intensity and 200 Cycles per burst. The sheared products were separated on an 8% Novex TBE gel (Invitrogen Canada, Inc.) and the 300-500 bp size fraction was excised and eluted into 300 ml of elution buffer containing 5:1 (vol/vol) LoTe (3 mM Tris-HCl, pH 7.5, 0.2 mN EDTA)/7.5 M ammonium acetate. The elute was purified from the gel slurry by centrifugation through a Spin-X centrifuge tube filter (Fisher Scientific Ltd) and EtOH precipitated. A paired-end library was constructed from the purified DNA following Illumina's protocol (Illumina Inc.). Briefly, the DNA was subjected to end-repair and phosphorylation by T4 DNA polymerase, Klenow DNA Polymerase and T4 Polynucleotide Kinase, respectively, in a single reaction, then 3 0 A overhangs were generated by Klenow fragment (3 0 to 5 0 exo minus). The modified DNA fragments were ligated to Illumina PE adapters, and the adapter-ligated products purified through a QIAquick spin column (Qiagen Inc.). The ligation products were subjected to six to ten cycles of PCR amplification using Illumina's PE primer set and Phusion DNA Polymerase (Thermo Fisher Scientific Inc.). The amplified products were separated from nonamplifiable damaged DNA fragments and adapter products on an 8% Novex TBE gel (Invitrogen Canada, Inc.) and purified as above. The purified Illumina library was assessed using an Agilent DNA 1000 Series II assay (Agilent Technologies Canada Inc.), quantified by qPCR according to the KAPA Biosystems Library Quantification Kit protocol (D-Mark Biosciences) and sequenced on Illumina's HiSeq2000 machines using paired-end 101 nt chemistry. Fig. 1 ). For each sample, total MeDIP-Seq read counts were normalized to 50 M, and MRE-Seq read counts were normalized to 35 M (ref. 20) . Given normalized MeDIPSeq and MRE-Seq read densities across all CpGs, the algorithm traces through each CpG sequentially, comparing read counts from both assays. An arbitrary score proportional to the read density was increased when the signals overlapped and decreased when they did not, and an additional penalty proportional to the distance between CpGs was assigned. When the score returned to zero at some distance following the initialization of an IM region, the end point of the region was defined as the position with the highest score following the start site. The IM detection algorithm and related data sets can be downloaded at http:// epigenome.wustl.edu/Intermediate_Methylation/. IM data filters. To limit the false detection of IM, we determined a length and score threshold by comparing IM calls derived from our data to calls from randomly shuffled data. Paired MeDIP-Seq and MRE-Seq read counts were randomly reassigned to CpGs, maintaining their paired relationship. The length and score distributions of IM calls from 1,000 random simulations were then compared with actual distributions, and cutoffs were selected to achieve an estimated false-positive rate of less than 1%. The minimum score was therefore set to 8.0, and the minimum length set to 100 bp (length cutoff was applied to the reference IM set).
Reference IM list assembly. The reference list of IM regions is intended as a summary of the IM landscape across all available samples, and represents the union of all IM regions that passed the data filters. IM regions within 100 bp were merged across all samples. We additionally required each reference list IM region to be present in at least 2 of the 25 samples analysed to further reduce false positives. These tasks were performed using applications from the BEDtools suite 42 .
The reference set and sample-specific IM regions can be found at http:// epigenome.wustl.edu/Intermediate_Methylation/.
Hierarchical clustering. To compare methylation at IM regions across all samples, we clustered samples based on three separate metrics: MeDIP-Seq read counts (distance metric ¼ Canberra); MRE-Seq read counts (distance metric ¼ Canberra) and binary presence or absence of IM state for each sample (distance metric ¼ Jaccard). We performed hierarchical clustering separately for each metric (clustering method ¼ average).
DNase I hypersensitivity. The set of DHSs was previously generated for the ENCODE database by combining peak calls from 41 different cell lines 43 .
VISTA enhancer validation. Human and mouse IM regions were intersected with the complete set of VISTA enhancers. The VISTA Project selects candidate enhancers based on ChIP-Seq and sequence conservation 28 . Regions were tested using in vivo reporter assays within mammalian embryos.
SNP heterozygosity and ASM tests. We analysed only SNPs that fell within reference IM regions, had a minimum read coverage of nine reads in both MeDIP and MRE assays (a maximum read cutoff of 100 was also applied to MRE data to limit influence of PCR bias), and were previously annotated in the database of single-nucleotide polymorphisms (dbSNPs) 44 . We called a SNP heterozygous if each allele was represented in at least 30% of MeDIP or MRE reads. As wholegenome sequencing data are available for one of the twin fetal brain samples, we measured the accuracy of the predicted genotypes for each of the corresponding twin brain samples. At loci where genotype was known from whole-genome sequencing, our criteria for predicting heterozygosity from MeDIP/MRE-Seq achieved a false-positive rate below 3% for each sample.
Of the SNPs categorized as heterozygous, we further classified them as allelespecifically methylated if they met the following criteria: (i) At least 75% of MeDIPSeq reads contained the same allele identity at the heterozygous locus, whereas at least 75% of MRE reads contained a variant allele; (ii) at least one assay (MeDIPSeq or MRE-Seq) showed a statistically significant skew towards one allele (Po0.01, Fisher's exact test).
Heterozygous SNPs qualified as allele-independent methylation if they met the following criteria: (i) neither MeDIP-Seq nor MRE-Seq had more than 70% of reads with the same allele identity at the heterozygous SNP locus; (ii) neither assay showed a statistically significant skew towards an allele (P40.01, Fisher's exact test).
We classified an IM region as ASM if it contained two or more ASM SNPs from any sample and no AIM SNPs. Similarly, we classified an IM region as AIM if it contained two or more AIM SNPs and no ASM SNPs. One hundred and thirty-six regions contained both ASM and AIM SNPs, and were ignored.
Comparing regions with different methylation levels. To compare ChIP-Seq signal levels between similarly sized and distributed IM, methylated and unmethylated regions, we examined regions that fell within the boundaries of the union of all sample IM regions, which are IM in at least one but not necessarily all samples. In a given sample, a region was defined as unmethylated if it carried four or more MRE-Seq reads and no MeDIP-Seq reads over at least 75% of CpGs within the region. Conversely, a region was defined as methylated if it carried four or more MeDIP-Seq reads and no MRE-Seq reads at 75% of CpGs or greater. These region definitions were used for comparison of histone modifications, DHS levels and expression of nearby genes.
Histone and DHS signals were measured in 100 bp bins starting from the centre of each region and extending ±5 kb. Signal level was calculated as reads per kilobase per millions of reads sequenced (RPKM), and a generalized additive model was used to approximate the shape of the signal within each group of regions (methylated, unmethylated and IM) across all bins within a 95% confidence interval 45 . CD8 Naïve and PBMC ChIP-Seq were taken from donors that were not included in the IM analysis (CD8N H3K4me3: GSM613811; CD8N H3K4me1: GSM613814; PBMC H3K4me3: GSM1127126; PBMC H3K4me1: GSM1127143). DNase-Seq data were from H1ES and fetal brain donors not included in the IM analysis (H1ES: GSM878616, fetal brain: GSM878651).
Gene expression and relative exon expression. Methylated, unmethylated and IM regions were associated with NCBI Reference Sequence (RefSeq) genes if they fell within 10 kb of the transcription start site of that gene (Total gene-associated regions: IM ¼ 6,776; methylated ¼ 3,270; unmethylated ¼ 5,605). Gene expression levels were measured as RPKM for each annotated gene transcript associated with a region.
Regions were associated with exons if they occurred within 1 kb of the exon (IM exons ¼ 14,336; methylated exons ¼ 6,642; unmethylated exons ¼ 9,331). Relative exon expression was measured using the following formula:
where R e is the RPKM value for a given exon and R t is the RPKM value for the transcript containing that exon.
Comparison of human and mouse IM. Mouse coordinates (mm9) were mapped to orthologous human regions using the UCSC LiftOver tool with minMatch parameter set to 0.8 (80% sequence identity). Additional data tables can be downloaded at http://epigenome.wustl.edu/Intermediate_Methylation/.
